Insight Lifetech Co., Ltd. (SHA:688712)

Market Cap	17.17B
Revenue (ttm)	486.00M +72.1%
Net Income	55.63M
EPS	0.12
Shares Out	417.00M
PE Ratio	308.66
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,382,764
Average Volume	9,521,621
Open	40.30
Previous Close	40.20
Day's Range	40.24 - 41.80
52-Week Range	39.40 - 55.80
Beta	n/a
RSI	n/a
Earnings Date	n/a

About Insight Lifetech

Insight Lifetech Co., Ltd. develops and manufactures medical technology solutions focused on precision intravascular physiology and imaging for the diagnosis and treatment of cardiovascular diseases. The company provides products in precision intravascular physiology and imaging, including FFR (Fractional Flow Reserve) and IVUS (Intravascular Ultrasound) systems. Its product portfolio addresses the diagnosis and treatment of conditions such as coronary heart disease and coronary artery disease, with offerings that include TrueVision and VivoHea...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2015
• Employees: 632
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688712

Financial Performance

In 2024, Insight Lifetech's revenue was 316.60 million, an increase of 72.09% compared to the previous year's 183.98 million. Losses were -53.74 million, -65.38% less than in 2023.